Skip to content

Evaluation of the effect of high dose interalipid administration versus its gradual increase in neonates weighing less than 1500

Evaluation of the effect of high dose interalipid administration versus its gradual increase in neonates weighing less than 1500

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160120026115N6
Enrollment
104
Registered
2018-02-17
Start date
2016-03-20
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advising of high doses interalipid.

Interventions

Intervention 1: Control group: this group started with an injectable lipid emulsion from 1 gr / kg per 24 hours and increase 1 gram daily to 3 grams per kilogram per 24 hours . We monitor neonate with

Sponsors

Vice chancellor for research of Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Days to 28 Days

Inclusion criteria

Inclusion criteria: All children born in Akbar Abadi Hospital with a birth weight of less than 1500 grams. Had no perinatal asphyxia (Apgar 5 minutes below 6). Parents had a written consent for entry into the study. Had no major anomalies.

Exclusion criteria

Exclusion criteria: If there is any evidence of sepsis before randomization If there is any evidence of metabolic acidosis before randomization hypoxia less than 90% before randomization

Design outcomes

Primary

MeasureTime frame
Triglyceride. Timepoint: Before the intervention, then twice a week. Method of measurement: laboratory kit.;Arterial blood gas analysis and blood bicarbonate. Timepoint: Before the intervention, then twice a week. Method of measurement: laboratory kit.;Blood glucose. Timepoint: Before the intervention and then daily. Method of measurement: laboratory kit.;Neonate weight. Timepoint: Before the intervention and then daily. Method of measurement: Scales.;CRP. Timepoint: Before the intervention, then twice a week. Method of measurement: laboratory kit.

Secondary

MeasureTime frame
Blood culture. Timepoint: Before intervention and then if symptoms of sepsis occur. Method of measurement: Observation of microbial growth in culture media.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMandana Kashaki

Iran University of Medical Sciences

kashakimd@gmail.com+98 21 5563 2277

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026